Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Dysfunctional maturation of neural networks, particularly hippocampus-prefrontal networks, may be of particular interest in determining the pathophysiology of schizophrenia. Phencyclidine (PCP)-induced symptoms in humans appear to offer a more complete model of schizophrenia than do amphetamine-induced symptoms. This study investigated the effects of intermittent i.p. injections of PCP (7.5 mg/kg) on cell proliferation and survival of granule cells in the dentate gyrus of the rat brain using quantitative immunohistochemical techniques for 5-bromo-2'-deoxyuridine (BrdU)-positive cells. After repeated PCP injection for 14 days, mean scores for stereotyped behavior increased with the number of injections, while scores for ataxia and backpedaling as serotonergic behaviors gradually decreased. The number of BrdU-positive cells decreased by 23% in the subgranular zone of the dentate gyrus by 24 h after repeated injections. However, decreased levels of BrdU-positive cells returned to control levels within 1 week. Differentiation of newly formed cells was not influenced. Repeated PCP administration after BrdU injection did not exert any effects on survival of newly generated cells. These findings suggest that transient disturbances of cell proliferation in the dentate gyrus occur under PCP-related behavioral abnormalities. Whether disturbed cell proliferation would thus be closely implicated in the development of behavioral sensitization induced by PCP administration is unclear, but this would possibly result from adaptation to new pharmacological conditions under behavioral sensitization or stressful conditions of PCP-related abnormal behaviors. Further studies are required to elucidate the biological significance of hippocampal neurogenesis in the mechanisms underlying the development of cognitive dysfunctions and the psychosis of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585 · cited 1×
“Previous studies have estimated the length of the cell cycle for granule cells as 16–25 h (Cameron and McKay, 2001; Nowakowski et al., 1989).”
BackgroundGould, E., McEwen, B. S., Tanapat, P., Galea, L. A. M., & Fuchs, E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02492.1997 · Cited by 1,496 · cited 2×
“These noncompetitive NMDA receptor antagonists increase cell proliferation in the dentate gyrus after single injection (Cameron et al., 1995; Gould et al., 1997; Nacher et al., 2001), while MK-801 attenuates ischemia-induced increases in BrdU-positive cells (Arvidsson et al., 2001), and mutant mice…”
BackgroundIncentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435 · cited 1×
“The critical neuroadaptations for addictive behaviors include the brain reward systems sensitized to the drugs, which do not mediate the pleasurable or euphoric effects of drugs (Robinson and Berridge, 2001).”
BackgroundOpiates inhibit neurogenesis in the adult rat hippocampus
Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W., & Nestler, E. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120552597 · Cited by 599 · cited 4×
“However, the loss of ability to proliferate newly cells in the present study is relatively small compared with those in previous reports in which marked alteration of new cells, ranging from 30 to 60% compared with controls, has been demonstrated following pharmacological treatments (Bai et al., 2003; Eisch et al., 20…”
BackgroundResultInfluentialIn vivo neurogenesis in the adult brain: regulation and functional implications
Fuchs, E., & Gould, E. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00130.x · Cited by 215
Bai, F., Bergeron, M., & Nelson, D. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00104-7 · Cited by 144 · cited 3×
“However, the loss of ability to proliferate newly cells in the present study is relatively small compared with those in previous reports in which marked alteration of new cells, ranging from 30 to 60% compared with controls, has been demonstrated following pharmacological treatments (Bai et al., 2003; Eisch et al., 20…”
BackgroundResultCircuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia†
Greene, R. (2001) · Hippocampus · doi:10.1002/hipo.1072 · Cited by 140 · cited 1×
“Greene (2001) and Heckers and Konradi (2002) have reviewed evidence for the involvement of decreased volume, selective reduction of neurons, and decreased expression of proteins and genes associated with GABAergic or glutamatergic neurons of the hippocampus in the pathophysiology of schizophrenia.”
BackgroundPhencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia
Le Pen, G., Grottick, A. J., Higgins, G. A., & Moreau, J.-L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300208 · Cited by 82
Nabeshima, T., Fukaya, H., Yamaguchi, K., Ishikawa, K., Furukawa, H., & Kameyama, T. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90753-9 · Cited by 69
Research works printed but not linked: 80
- Abe, 2001, Neuropsychopharmacology, 25, 173, 10.1016/S0893-133X(00)00250-5 · DOI
- Abe, 2005, Prog Neuropsychopharmacol Biol Psychiatry, 29, 133, 10.1016/j.pnpbp.2004.10.015 · DOI
- Adams, 1998, J Neurosi, 18, 5545
- Arvidsson, 2001, Eur J Neurosci, 14, 10, 10.1046/j.0953-816x.2001.01611.x · DOI · Paper page
- Banasr, 2004, Neuropsychopharmacology, 29, 450, 10.1038/sj.npp.1300320 · DOI · Paper page
- Becker, 2003, Prog Neuropsychopharmacol Biol Psychiatry, 27, 687, 10.1016/S0278-5846(03)00080-0 · DOI · Paper page
- Benes, 1999, Biol Psychiatry, 46, 589, 10.1016/S0006-3223(99)00136-5 · DOI · Paper page
- Brezun, 1999, Neuroscience, 89, 999, 10.1016/S0306-4522(98)00693-9 · DOI · Paper page
- Brezun, 2000, Eur J Neurosci, 12, 391, 10.1046/j.1460-9568.2000.00932.x · DOI · Paper page
- Cameron, 1994, Neuroscience, 61, 203, 10.1016/0306-4522(94)90224-0 · DOI · Paper page
- Cameron, 1995, J Neurosci, 15, 4687, 10.1523/JNEUROSCI.15-06-04687.1995 · DOI · Paper page
- Carlezon, 2002, Trends Neurosci, 25, 610, 10.1016/S0166-2236(02)02289-0 · DOI · Paper page
- Castellani, 1981, Eur J Pharmacol, 73, 143, 10.1016/0014-2999(81)90086-8 · DOI
- Castner, 2004, Psychopharmacology, 174, 111, 10.1007/s00213-003-1710-9 · DOI · Paper page
- Conn, 1997, Annu Rev Pharmacol Toxicol, 37, 205, 10.1146/annurev.pharmtox.37.1.205 · DOI · Paper page
- Corso, 1997, Brain Res, 752, 1, 10.1016/S0006-8993(96)01347-9 · DOI
- Dawirs, 2001, Acta Psychiatr Scand, 104, 10, 10.1034/j.1600-0447.2001.104s408010.x · DOI
- Druhan, 1999, Behav Brain Res, 102, 195, 10.1016/S0166-4328(99)00017-0 · DOI
- Duncan, 2001, Neuropsychopharmacology, 25, 72, 10.1016/S0893-133X(00)00240-2 · DOI
- Eisch, 2002, Prog Brain Res, 138, 315, 10.1016/S0079-6123(02)38085-3 · DOI
- Emsley, 2005, Prog Neurobiol, 75, 321, 10.1016/j.pneurobio.2005.04.002 · DOI · Paper page
- Feron, 1999, Schizophr Res, 40, 211, 10.1016/S0920-9964(99)00055-9 · DOI
- Gasbarri, 1994, Brain Res Bull, 33, 445, 10.1016/0361-9230(94)90288-7 · DOI · Paper page
- Gould, 1992, J Neurosci, 12, 3642, 10.1523/JNEUROSCI.12-09-03642.1992 · DOI · Paper page
- Halim, 2004, Neuropsychopharmacology, 29, 1063, 10.1038/sj.npp.1300422 · DOI · Paper page
- Hanania, 1999, Synapse, 31, 229, 10.1002/(SICI)1098-2396(19990301)31:3<229::AID-SYN8>3.0.CO;2-3 · DOI
- Harrison, 2001, Hippocampus, 11, 508, 10.1002/hipo.1067 · DOI · Paper page
- Hayase, 2002, Pharmacol Biochem Behav, 71, 19, 10.1016/S0091-3057(01)00585-8 · doi:10.1016/s0091-3057(01)00585-8
- Heckers, 2002, J Neural Transm, 109, 891, 10.1007/s007020200073 · DOI · Paper page
- Heidbreder, 1996, Synapse, 24, 182, 10.1002/(SICI)1098-2396(199610)24:2<182::AID-SYN10>3.0.CO;2-0 · DOI
- Ho, 2005, Am J Psychiatry, 162, 1527, 10.1176/appi.ajp.162.8.1527 · DOI
- Hori, 2000, Neurosci Lett, 280, 53, 10.1016/S0304-3940(99)00991-X · DOI
- Ito, 2002, Pharmacol Biochem Behav, 65, 705, 10.1016/S0091-3057(99)00263-4 · DOI
- Javitt, 1991, Am J Psychiatry, 148, 1301, 10.1176/ajp.148.10.1301 · DOI · Paper page
- Jentsch, 1997, Science, 277, 953, 10.1126/science.277.5328.953 · DOI · Paper page
- Jentsch, 1998, Neuropsychopharmacology, 19, 105, 10.1016/S0893-133X(98)00004-9 · DOI · Paper page
- Kalivas, 1993a, J Neurosci, 13, 266, 10.1523/JNEUROSCI.13-01-00266.1993 · DOI · Paper page
- Kalivas, 1993b, J Neurosci, 13, 276, 10.1523/JNEUROSCI.13-01-00276.1993 · DOI · Paper page
- Keilhoff, 2004, Biol Psychiatry, 56, 317, 10.1016/j.biopsych.2004.06.010 · DOI
- Kempermann, 2003, Biol Psychiatry, 54, 499, 10.1016/S0006-3223(03)00319-6 · DOI · Paper page
- Kempermann, 2004a, Trends Neurosci, 27, 447, 10.1016/j.tins.2004.05.013 · DOI · Paper page
- Kempermann, 2004b, Curr Opin Neurobiol, 14, 186, 10.1016/j.conb.2004.03.001 · DOI · Paper page
- Kitamura, 2003, Neurosci Res, 47, 55, 10.1016/S0168-0102(03)00171-8 · DOI
- Lannes, 1991, Neurosci Lett, 128, 177, 10.1016/0304-3940(91)90255-R · DOI
- Lindahl, 2004, Neuropsychopharmacology, 29, 2065, 10.1038/sj.npp.1300485 · DOI
- Mackler, 2000, J Neurosci, 20, 6210, 10.1523/JNEUROSCI.20-16-06210.2000 · DOI
- Malberg, 2000, J Neurosci, 20, 9104, 10.1523/JNEUROSCI.20-24-09104.2000 · DOI · Paper page
- Martin, 1979, Life Sci, 24, 1699, 10.1016/0024-3205(79)90255-8 · DOI
- Masuo, 1997, Brain Res Brain Res Protoc, 1, 321, 10.1016/S1385-299X(97)00005-6 · doi:10.1016/s1385-299x(97)00005-6
- Murray, 2002, J Psychol, 136, 319, 10.1080/00223980209604159 · DOI · Paper page
- Nabeshima, 1984, Pharmacol Biochem Behav, 21, 401, 10.1016/S0091-3057(84)80102-1 · DOI
- Nacher, 2001, Eur J Neurosci, 13, 512, 10.1046/j.0953-816x.2000.01424.x · DOI · Paper page
- Nicoletti, 1996, Trends Neurosci, 19, 267, 10.1016/S0166-2236(96)20019-0 · DOI · Paper page
- Nowakowski, 1989, J Neurocytol, 18, 311, 10.1007/BF01190834 · DOI · Paper page
- Olney, 1995, Neuropsychopharmacology, 13, 335, 10.1016/0893-133X(95)00079-S · DOI · Paper page
- Pechnick, 1989a, J Pharmacol Exp Ther, 250, 534
- Pechnick, 1989b, Eur J Pharmacol, 164, 257, 10.1016/0014-2999(89)90466-4 · DOI
- Prickaerts, 2004, Neurobiol Learn Mem, 81, 1, 10.1016/j.nlm.2003.09.001 · DOI
- Radley, 2002, Brain Res, 955, 264, 10.1016/S0006-8993(02)03477-7 · DOI · Paper page
- Ricci, 2004, Pharmacol Biochem Behav, 77, 415, 10.1016/j.pbb.2003.10.005 · DOI
- Ritz, 1990, Life Sci, 46, 635, 10.1016/0024-3205(90)90132-B · DOI · Paper page
- Seki, 2003, Anat Sci Int, 78, 69, 10.1046/j.0022-7722.2003.00043.x · DOI
- Smith, 1977, Biochem Pharmacol, 26, 1435, 10.1016/0006-2952(77)90370-7 · DOI · Paper page
- Snyder, 1980, Nature, 285, 355, 10.1038/285355a0 · DOI · Paper page
- Steinpreis, 1993, Brain Res, 612, 263, 10.1016/0006-8993(93)91671-E · DOI
- Sturgeon, 1979, Eur J Pharmacol, 59, 169, 10.1016/0014-2999(79)90279-6 · DOI · Paper page
- Sturgeon, 1982, Psychopharmacology, 76, 52, 10.1007/BF00430755 · DOI
- Suzuki, 2000, Synapse, 38, 198, 10.1002/1098-2396(200011)38:2<198::AID-SYN11>3.0.CO;2-K · DOI
- Tani, 2001, Br J Pharmacol, 134, 1411, 10.1038/sj.bjp.0704370 · doi:10.1038/sj.bjp.0704370
- Teuchert-Noodt, 2000, J Neural Transm, 107, 133, 10.1007/s007020050012 · DOI
- Tsai, 1995, Arch Gen Psychiat, 52, 829, 10.1001/archpsyc.1995.03950220039008 · DOI · Paper page
- Ujike, 1990, Psychopharmacology, 102, 459, 10.1007/BF02247125 · DOI
- Wakade, 2002, J Neurosci Res, 69, 72, 10.1002/jnr.10281 · DOI · Paper page
- Walker, 2002, Am J Psychiatry, 159, 821, 10.1176/appi.ajp.159.5.821 · DOI · Paper page
- Wang, 1999, J Neurosci Res, 55, 762, 10.1002/(SICI)1097-4547(19990315)55:6<762::AID-JNR10>3.0.CO;2-E · DOI
- Wang, 2004, Neuropsychopharmacology, 29, 1230, 10.1038/sj.npp.1300449 · DOI · Paper page
- Wang, 1997, J Neurosci, 17, 5993, 10.1523/JNEUROSCI.17-15-05993.1997 · DOI
- Yamaguchi, 2002, Synapse, 58, 63, 10.1002/syn.20182 · DOI
- Yoshida, 1988, Experientia, 44, 700, 10.1007/BF01941033 · doi:10.1007/bf01941033
- Yu, 2002, Neuroscience, 113, 1, 10.1016/S0306-4522(02)00163-X · DOI
Cited by
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508
Neuroinflammation in schizophrenia especially focused on the role of microglia
Monji, A., Kato, T. A., Mizoguchi, Y., Horikawa, H., Seki, Y., Kasai, M., Yamauchi, Y., Yamada, S., & Kanba, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.12.002 · Cited by 314
Bussey, T. J., Holmes, A., Lyon, L., Mar, A. C., McAllister, K. A. L., Nithianantharajah, J., Oomen, C. A., & Saksida, L. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.011 · Cited by 299
Hippocampal neurogenesis as a target for the treatment of mental illness: A critical evaluation
DeCarolis, N. A., & Eisch, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.013 · Cited by 252
Male/female differences in neuroprotection and neuromodulation of brain dopamine
Bourque, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00035 · Cited by 40
Metadata
- Authors
- Liu, J., Suzuki, T., Seki, T., Namba, T., Tanimura, A., & Arai, H.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2006
- Volume
- 60
- Issue
- 1
- Pages
- 56-68
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1973429276
- Cited by
- 52
- References
- 10
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 3530 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat. https://app.cochat.ai/papers/10.1002/syn.20275
- The paper
- Liu, J., Suzuki, T., Seki, T., Namba, T., Tanimura, A., & Arai, H. (2006). Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat. Synapse. https://doi.org/10.1002/syn.20275
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.